ALTO-207 in Adults With Treatment-resistant Depression (TRD)
for Treatment-resistant Depression (TRD)
Sites in Syracuse, Amherst +36 more locations
Sponsor: Alto Neuroscience
Sex: All·Age: 18 - 75
Code: NCT07553637·Phase 2·Recruiting·Listed Apr 2026
Paid Clinical Trials in Syracuse, NY
As of August 2026, 179 paid clinical trials are recruiting in Syracuse, New York. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Filter results
168 clinical trials
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
for Prostate Cancer
Drug: Saruparib
Sites in Syracuse, New York +36 more locations
Sponsor: AstraZeneca
Sex: Male·Age: 18+
Code: NCT06952803·Phase 3·Recruiting·Listed May 2025
Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
for Endometrial Carcinoma
Sites in Syracuse, Webster +325 more locations
Sponsor: National Cancer Institute (NCI)
Sex: Female·Age: 18+
Code: NCT05256225·Phase 3·Recruiting·Listed Feb 2022
A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
for Systemic Sclerosis
Sites in Syracuse, New York +13 more locations
Sponsor: Nkarta, Inc.
Sex: All·Age: 18 - 75
Code: NCT06733935·Phase 1, Phase 2·Recruiting·Listed Dec 2024
A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE
for Lupus Erythematosus, Systemic
Sites in Syracuse, New York +11 more locations
Sponsor: AstraZeneca
Sex: All·Age: 18 - 70
Code: NCT06897930·Phase 1, Phase 2·Recruiting·Listed Mar 2025
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
for Chronic Obstructive Pulmonary Disease (COPD)
Sites in Syracuse, Staten Island +60 more locations
Sponsor: AstraZeneca
Sex: All·Age: 40 - 80
Code: NCT06878261·Phase 3·Recruiting·Listed Mar 2025
A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)
for Lupus Nephritis
Sites in Syracuse, New York +14 more locations
Sponsor: Nkarta, Inc.
Sex: All·Age: 18 - 75
Code: NCT06557265·Phase 1, Phase 2·Recruiting·Listed Aug 2024